Stock overview
Bristol-Myers Squibb Co.
Explore the company, reported ownership, price history, and available source evidence.
Bristol Myers Squibb develops medicines for oncology, immunology, cardiovascular disease, and hematology.
- Last close
- $62.86
- · BMY
- Tracked holders
- 1 fund
- Latest available 13F per fund
BMY · USD
Price
$62.86
-$0.97
(-1.52%)
over selected range
Close · Sep 25, 2026
Market closed
30 stored daily closes
$62.86
Sep 25, 2026
- Range low
- $61.15
- Range high
- $68.09
- Observations
- 30
- Session date
- Sep 25, 2026
Aug 14, 2026–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Gotham Asset Management largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | +4% 26'Q2 | $51,452,874 | 0.12% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market